CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Shares withheld for taxes | −318 | $88.69 | $28K | 39,886.97 |
| 2022-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise · Restricted Stock Unit | −928 | 930 | ||
| 2022-05-01 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Option exercise | +866 | $88.69 | $77K | 14,088.88 |
| 2022-05-01 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Shares withheld for taxes | −427 | $88.69 | $38K | 13,661.88 |
| 2022-05-01 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Option exercise · Restricted Stock Unit | −866 | 866 | ||
| 2022-05-01 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise | +866 | $88.69 | $77K | 14,924.93 |
| 2022-05-01 | Klobuchar Michael A EVP - Chief Strategy Officer | Shares withheld for taxes | −427 | $88.69 | $38K | 14,497.93 |
| 2022-05-01 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise · Restricted Stock Unit | −866 | 866 | ||
| 2022-05-01 | Garay Arpa SVP Human Health Global Mktg. | Option exercise | +866 | $88.69 | $77K | 1,156 |
| 2022-05-01 | Garay Arpa SVP Human Health Global Mktg. | Shares withheld for taxes | −247 | $88.69 | $22K | 909 |
| 2022-05-01 | Garay Arpa SVP Human Health Global Mktg. | Option exercise · Restricted Stock Unit | −866 | 866 | ||
| 2022-03-31 | WENDELL PETER C Director | Grant or award · Phantom Stock | +365.63 | $82.05 | $30K | 111,460.69 |
| 2022-03-31 | Seidman Christine E Director | Grant or award · Phantom Stock | +198.05 | $82.05 | $16K | 7,362.28 |
| 2022-03-31 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +137.11 | $82.05 | $11K | 80,714.7 |
| 2022-03-31 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +396.1 | $82.05 | $32K | 13,344.79 |
| 2022-02-24 | Zachary Jennifer EVP, General Counsel | Grant or award | +18,420 | $73.51 | $1.4M | 53,419.17 |
| 2022-02-24 | Williams David Michael EVP,Chief Info&Digital Officer | Grant or award | +1,660 | $73.51 | $122K | 8,603.76 |
| 2022-02-24 | MIZELL STEVEN EVP, Chief HR Officer | Grant or award | +14,571 | $73.51 | $1.1M | 40,144.15 |
| 2022-02-24 | Litchfield Caroline EVP & CFO | Grant or award | +2,429 | $73.51 | $179K | 26,555.81 |
| 2022-02-24 | Li Dean Y Executive VP & President, MRL | Grant or award | +3,023 | $73.51 | $222K | 15,462.12 |
Page 38 of 42 · 823 trades